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Summary
Background: Data on the use of phytotherapy in primary
care are scarce and difficult to compare (e.g. different
health-care systems, study designs). Objective: Are there
differences in Switzerland regarding demographic data,
practice structure, process of care and outcome/
treatment satisfaction between primary care physicians
certified in phytotherapy (CAM) and physicians perform-
ing conventional primary care (COM) and their patients?
Material and Methods: Subgroup analysis of the data of
phytotherapy of an observational study (2 cross-section-
al surveys with 3 questionnaires) which was performed
as part of a nationwide evaluation program on comple-
mentary medicine (PEK). A descriptive analysis was used
to compare data. Results: In survey A, 20 CAM and 191
COM physicians participated, of which 14 and 84, respec-
tively, continued for survey B and recruited at least 276
CAM and 1,395 COM patients. Findings show that CAM
physicians had less technical equipment (e.g. x-rays)
than COM physicians, their consultation time was 25%
longer, and they used more non-drug therapies. Whereas
in the SF-36 no differences could be identified between
the groups, the EUROPEP showed significant differences
in favour of CAM patients. Conclusions: Preliminary data
of the comparison between CAM and COM physicians
indicate few differences in demographic and practice
structure data. Yet, due to differences in the process of
care CAM patients showed better treatment satisfaction
than COM patients. This is probably due to their doctors’
communicative qualities and patient-oriented skills. To
which degree this might be triggered due to phyto-phar-
macosemiotic aspects needs to be investigated in a fu-
ture study.
Schlüsselwörter 
Phytotherapie · PEK · Beobachtungsstudie · Grund -
versorgung · SF-36 · EUROPEP · Pharmakosemiotik
Zusammenfassung
Hintergrund: Daten zum Gebrauch der Phytotherapie 
in der ärztlichen Grundversorgung sind rar und kaum
vergleichbar (z.B. unterschiedliche Gesundheitssysteme,
Studiendesigns). Fragestellung: Gibt es in der Schweiz
Unterschiede hinsichtlich Demografie, Praxisstruktur, Be-
handlungsprozess und Behandlungsergebnis zwischen
Ärzten in der Grundversorgung, die in Phytotherapie zer-
tifiziert sind (CAM), und konventionellen Grundversor-
gern (COM) und ihren jeweiligen Patienten? Methoden:
Subgruppenanalyse der Daten zur Phytotherapie aus der
Beobachtungsstudie (2 Querschnittsbefragungen mit 3
Fragebögen) im Rahmen des Programms zur Evaluation
der Komplementärmedizin (PEK). Der Vergleich der
Daten erfolgt mit beschreibender Statistik. Ergebnisse:
An Befragung A nahmen 20 CAM- und 191 COM-Ärzte
teil. Davon beteiligten sich 14 bzw. 84 Ärzte an Befragung
B, wobei sie je nach Fragebogen mindestens 276 CAM-
und 1395 COM-Patienten rekrutieren konnten. Es zeigt
sich, dass CAM-Ärzte weniger technische Geräte (z.B.
Röntgengeräte) als COM Ärzte besitzen, ihre Konsulta-
tionszeit 25% länger ist und sie mehr nichtmedikamentö-
se Behandlungen einsetzen. Während sich im SF-36 kein
Unterschied im Behandlungsergebnis fand, zeigte der
EUROPEP ein besseres Ergebnis bei CAM-Patienten.
Schlussfolgerungen: Die vorläufige Analyse der Daten
zeigt im Vergleich von CAM- und COM-Ärzten wenige
Unterschiede hinsichtlich demografischer Daten oder
Praxisstruktur. Jedoch wirken sich Unterschiede im Be-
handlungsprozess, offenbar durch Patientenorientierung
und kommunikative Qualitäten der CAM-Ärzte, positiv
auf die Patientenzufriedenheit aus. Inwiefern phytophar-
makosemiotische Aspekte eine Rolle spielen, müsste in
einer weiteren Studie untersucht werden.
Dr. med. Jörg Melzer
Institute of Complementary Medicine
Department of Internal Medicine, University Hospital Zurich, 
Raemistrasse 100, CH-8091 Zurich, Switzerland
Tel. +41 44 255-2460, Fax -4394
E-mail joerg.melzer@usz.ch
© 2008 S. Karger GmbH, Freiburg
Accessible online at: 
www.karger.com/fok
Fax +49 761 4 52 07 14
E-mail Information@Karger.de
www.karger.com
Wissenschaft  •  Praxis  •  Perspektiven
082_088_09002_melzer:082_088_09002_melzer  23.04.2008  13:37 Uhr  Seite 82
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
7/
7/
20
16
 1
1:
19
:1
5 
AM
Introduction
In the past decades, the Swiss health care system underwent
changes regarding the development of alternative and com-
plementary medicine (CAM) provided by physicians, and
some of these especially affected phytotherapy: (1) in 1988,
the foundation of the Swiss Medical Association for Phy-
totherapy (Schweizerische Medizinische Gesellschaft für Phy-
totherapie – SMGP), which is a founding member of the Eu-
ropean Scientific Cooperative on Phytotherapy (ESCOP) [1];
(2) in 1990, the start-up of a certification program in phy-
totherapy for physicians by the SMGP [2]; (3) in 1994, the set-
up of a chair and an institute of complementary medicine at
the University of Zurich – focusing on research in phytothera-
py [3]; (4) from 1999 on, an increasing inclusion of herbal
preparations into the specialty list if efficacy, cost efficiency
and utility are given (‘Spezialitätenliste’ [4]), and coverage by
basic health insurance.
In 1999, the Swiss Medical Association (Federatio Medicorum
Helveticorum – FMH) accredited certificates to physicians for
the qualification programs (‘Fähigkeitsprogramme’) of some
Swiss CAM organisations, like anthroposophic medicine,
homeopathy and neural therapy. But the qualification pro-
gram of the SMGP for phytotherapy was not certified by the
FMH, for political reasons. It was argued that, in fact, any
Swiss physician can prescribe herbal medicinal products
(HMP) licensed by Swiss health authorities (Swissmedic, Fed-
eral Office of Public Health) without the need of any certifi-
cate in phytotherapy. For Chinese herbal medicine (TCM), no
Forsch Komplementärmed 2008;15:82–88Quality Aspects of Phytotherapy in Swiss 
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FMH certificate or single training course was available. But as
Chinese herbal medicine is somehow part of the FMH-certi-
fied training course for acupuncture (TCM), this course was
accepted as kind of an equivalent qualification. 
Despite these differences in accreditation of CAM certificates,
a nationwide program on the evaluation of complementary
medicine (PEK) was released in Switzerland. Therefore, the
Swiss government founded a steering group and a scientific
review board to organize the evaluation and the set-up of re-
search strategies and methods to be used. Institutions were
chosen to put the PEK into practice in cooperation with the
steering group [5]. Each of the 5 CAM methods (anthropo-
sophic medicine, Chinese herbal medicine, homeopathy, neur-
al therapy, and ‘Western’ phytotherapy – that is phytotherapy
based on European cultures) were to be evaluated on 3 levels:
(1) by a literature review to give an overview of CAM practice
in Switzerland as well as to gain estimates on efficacy and
costs (partly published in HTAs [6–8]) or systematic reviews
[9–12]; (2) by an observational study with 2 surveys (and 
3 questionnaires: physician questionnaire, physician-patient
questionnaire, patient questionnaire) in outpatient clinics
(partly published [13–15]); (3) by a clinical trial to evaluate ef-
ficacy and safety of treatments – which did not take place [6].
To date, only few studies focusing on the evaluation of efficacy
of phytotherapy in primary care are available worldwide. Most-
ly, they examine patients’ characteristics [16–18] and seldom
those of physicians [19]. A comparison of the existing studies is
hardly possible, due to the differing health care systems, study
designs and cultures where phytotherapy was used.
Survey A: Physician Questionnaire (structural + demographic aspects)
20 CAM  
physicians 
191 COM 
physicians 
14 CAM 
physicians 
3,078 adult 
patients 
575 adult 
patients 
84 COM 
physicians 
Survey B+: 1 – Physician-Patient Questionnaire (process of care)
Survey B+: 2 – Patient Questionnaire (outcome/treatment satisfaction)
return rates: 
45 %  54 %
276 adult 
patients 
1,395 adult 
patients 
return rates: 
31 %  29 %
Fig. 1. Flowchart on the sampling for the 
2 cross-sectional surveys (CAM physicians =
physicians additionally certified in phyto -
therapy; COM physicians = physicians
 without a certificate in phytotherapy 
(‘conventional’ physicians); + = number of
participating patients vary depending on
questionnaires and questions).
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Therefore, the aim of the present paper is to give a first
overview of the use of phytotherapy by primary care physi-
cians in Switzerland (i.e. demographic data, practice structure,
process of care and outcome/treatment satisfaction). For this
reason, we analyzed the subset of data on phytotherapy from
the PEK study [20], because in the previous publications the
data are included in a larger group of non-certified CAM
physicians [13–15], that is to say not certified by the FMH.
Methods
Study Design
The data of the observational study with 2 cross-sectional surveys con-
taining 3 questionnaires, were collected in practices of primary care
providers in Switzerland and were provided by the Swiss Federal Office of
Public Health (BAG) [21] after the study was performed by the Institute
for Evaluative Research in Orthopedic Surgery (IEFO), Bern. The study
focused on aspects of practice structure, demographic data of physicians
and patients, process of care, and outcome/treatment satisfaction [22].
Physicians additionally qualified in phytotherapy (CAM physicians) were
compared with physicians providing only conventional medicine (COM
physicians), and so were their respective patients (fig. 1). For sampling, a
list of CAM physicians was obtained from the SMGP, and a random sam-
ple of COM physicians (who declared not to use CAM and who were not
listed as members of CAM medical associations) was obtained from the
FMH. To be included, physicians had to work in primary care (e.g. general
practitioners) for ≥2 days a week. To have more robust data for this sub-
group analysis, we decided to include all COM physicians involved in the
main study [13], which accounts for the obvious difference in numbers of
CAM and COM participants (see fig. 1). The 2 consecutive surveys of the
study covered the following aspects:
Survey A – Physician Questionnaire: To investigate structural aspects of
the physicians’ practices and demographic data about physicians them-
selves, a questionnaire covering 9 sections with predominantly closed
questions was used. The questionnaire with an accompanying letter ex-
plaining the purpose of the trial was mailed to the physicians in summer
2002. A reminder letter was sent to non-responders 1 month later. Addi-
tional qualitative data about the philosophy of care (open questions –
data not shown) have not been analyzed for phytotherapy so far [14].
Survey B – (1) Physician-Patient Questionnaire: To gain information about
the process of care, CAM and COM physicians taking part in survey A
were asked to also participate in survey B. The patients’ questionnaire
contained closed questions about demographic data, as well as self-rating
of health status, and an open question about the severity of the symptoms.
The physicians’ questionnaire contained closed questions about the diag-
nostic procedure used with each individual patient, classification of the
main diagnosis, therapeutic procedure, sick leave, and consultation time. 
Physicians and their staff were instructed to sample consecutive patients
consulting their practices at 4 given days during a 12 months period in
2002/03 (winter, spring, summer and fall). Sampling days were defined by
the study coordination (IEFO) and were distributed equally across week
days. Patients were informed about the study by leaflets and were asked
to fill in the questionnaires prior to consultation. Physicians were asked to
document the respective consultation but were not aware of the patients’
answers.
Survey B – (2) Patient Questionnaire: Outcome/treatment satisfaction was
measured using a questionnaire mailed to patients 3–4 weeks after part 1
of survey B in 2003/04. The questionnaire contained 2 validated instru-
ments (SF-36 [23] and EUROPEP – European task force on patient eval-
uation of practice [24, 25]) – and 1 list of closed questions, not validated
(e.g. treatment expectations, side effects).
84 Forsch Komplementärmed 2008;15:82–88 Melzer/Saller/Meier
In 4-lingual Switzerland, all questionnaires were provided in French, Ger-
man or Italian, depending on the physicians’ and patients’ mother tongue.
All questionnaires were developed or chosen in close cooperation with
the PEK steering group and an expert group of Swiss primary care
providers specialized in COM and CAM. All participants cooperated on a
voluntary basis, and physicians were compensated with 500 CHF (330
EUR). The Bern ethics committee did not raise any objections to this
study.
Data Management and Data Analysis
Data were recorded by the IEFO using a relational database. Forms filled
in by patients and physicians were coded and recorded manually. A team
of 3 persons (2 physicians, 1 pharmacist) coded the main diagnoses and all
co-morbidities, according to the international statistical classification of
diseases (ICD-10) and related health problems. In the case of differing
classifications, team consent was found. Questionnaires mailed to patients
1 month after the initially recorded consultations were designed as ma-
chine-readable and were recorded by the Swiss Federal Office of Infor-
mation Technology, using Optical Character Recognition procedures.
Subgroup analysis of the data concerning phytotherapy from the observa-
tional study was performed in a descriptive way using tables and graphs
(i.e. mean, 95% confidence interval (CI). Next to this a multivariate linear
model (e.g. adjustment for age, sex, or physician’s practice) was addition-
ally used for the sum scores of the EUROPEP (p < 0.05). SAS 9.1 (SAS
Institute Inc., Cary, NC, USA) was used for all calculations.
Results
At the time the observational study took place, only a small
number of CAM physicians were certified in phytotherapy
which can explain the difference in numbers (almost 10 times
as many COM physicians as CAM physicians participated).
Therefore, we regard the following results as preliminary.
Survey A – Physician Questionnaire: The sample contained 20
primary care providers for CAM (additionally certified in
phytotherapy) and 191 for COM (table 1). The only signifi-
cant demographic difference between these 2 groups was the
lack of French-speaking and Italian-speaking CAM physi-
cians. This is not surprising, because up to 2003, the SMGP
only ran German training courses in phytotherapy. With re-
gard to structural aspects, the practices of CAM physicians
were significantly less equipped with X-ray facilities than
those of COM physicians (table 2).
Survey B – (1) Physician-Patient Questionnaire: Of the physi-
cians participating in survey A, 14 CAM and 84 COM physi-
cians also took part in survey B and recruited max. 575 and
3,078 adult patients, respectively (fig. 1). A rate of return of
questionnaires was not registered as the survey took place in
the physicians’ practices, without a recording of patients’ de-
nial to participate. As to patients’ demographic data, it could
be seen that the total number of male CAM patients was
lower than that of male COM patients (table 3). Not surpris-
ingly, the language differences found among physicians were
similar to those among patients. Nevertheless, there were
some French-speaking and Italian-speaking patients.
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Patients’ self-rating of their general health was similar in the
adult populations in both groups when the answers were di-
chotomized according to ‘excellent, very good, good’ versus
‘less good, bad’. The same holds for the severity of the main
health problem (table 4). 
Diagnostic procedures did not differ in the frequency of their
use, neither regarding technical approaches (e.g. laboratory or
radiological tests) nor regarding personal approaches (e.g.
anamnesis, physical examination) (table 5).
Forsch Komplementärmed 2008;15:82–88Quality Aspects of Phytotherapy in Swiss 
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Table 1. Demographic data of physicians– survey A
CAM sample COM sample
n (%) [CI] n (%) [CI]
Physicians, total 20 (100) [–] 191 (100) [–]
Age, years, mean 52.9 (median 55.0) 52.5 (median 54.0)
Language
– German 20 (100) [100–100] 126 (66) [59.2–72.7]
– French – 61 (31.9) [25.3–38.6]
– Italian – 4 (2.1) [0.0–4.1]
Sex
– Male 16 (80) [62.3–97.7] 167 (87.4) [ 82.7–92.2]
– Female 4 (20) [2.3–37.7] 24 (12.6) [7.8–17.3]
Years since graduation, 
mean 21.7 (median 22.5) 23.2 (median 24)
Workload, hours, mean 50 (median 50.6) 53.7 (median 55)
CI = 95% confidence interval; n = number. 
Table 2. Structural data regarding physicians’ practices – survey A
CAM sample COM sample
n (%) [CI] n (%) [CI]
Type of practice
– Single 15 (78.9) [60.5–97.4] 133 (69.6) [63.1–76.2]
– Group with SB 3 (15.8) [0.0–32.3] 43 (22.5) [16.5–28.5]
– Group with PB 1 (5.3) [0.0–15.4] 15 (7.9) [4.0–11.7]
Equipment
– Lab 17 (85) [69.2–100] 183 (95.8) [92.9–98.7]
– ECG 17 (85) [69.2–100] 186 (97.4) [95.1–99.7]
– X-ray 9 (45.0) [23.0–67.0] 155 (81.2) [75.6–86.7]
– Sono 6 (30.0) [9.8–50.2] 50 (26.2) [19.9–32.5]
Staff
– Secretary 6 (30) [9.8–50.2] 57 (29.8) [23.3–36.4]
– Assistant 16 (80) [62.3–97.7] 185 (96.9) [94.4–99.4]
– Lab assistant 4 (20) [2.3–37.7] 37 (19.4) [13.7–25.0]
– Therapist 4 (20) [2.3–37.7] 7 (3.7) [1.0–6.4]
Localization
– Inner city 11 (55) [33.0–77.0] 66 (34.6) [27.8–41.4]
– Agglomeration 5 (25) [5.9–44.1] 78 (40.8) [33.8–47.9]
– Segregated city – 5 (2.6) [0.3–4.9]
– Rural area 4 (20) [2.3–37.7] 42 (22) [16.1–27.9]
Lab = laboratory; PB = pooled billing; SB = separate billing; sono = ultra-
sound. 
Table 3. Demographic data regarding all patients – survey B
CAM sample COM sample
n (%) [CI] n (%) [CI]
Patients, total 616 (100) [–] 3263 (100) [–]
Age, years
– ≤16 (children), n 41 (mean 8.8, 185 (mean 10.9, 
median 7.5) median12)
– >16 (adults), n 575 (mean 50.9, 3078 (mean 52.0, 
median 51) median 52) 
Sex 
Male, total 236 (38.3) [29.0–47.6] 1418 (43.5) [53.4–59.7]
– Children 19 (46.3) [34.0–58.7] 74 (40.0) [33.5–46.5]
– Adults 217 (37.7) [28.2–47.3] 1344 (43.7) [40.4–46.9]
Female, total 380 (61.7) [52.4–71.0] 1845 (56.5) [53.4–59.7]
– Children 23 (53.7) [41.3–66.0] 111 (60.0) [53.5–66.5]
– Adults 358 (62.3) [52.7–71.8] 1734 (56.3) [53.1–59.6]
Mother tongue, total
– German 527 (85) [77.4–92.6] 1841 (56.2) [46.3–66.1]
– French 9 (1.5) [0.5–2.4] 879 (26.8) [17.8–35.9]
– Italian 43 (6.9) [0.0–14.5] 287 (8.8) [3.8–13.7]
– Other 41 (6.6) [4.4–8.8] 271 (8.3) [6.8–9.7]
Higher education
– Adults 102 (17.8) [11.2–24.4] 603 (19.9) [17.7–22.2]
Table 4. Patients’ self-rated health status (all patients) – survey B
CAM sample COM sample
n (%) [CI] n (%) [CI]
General health
– Bad / less wella 140 (25.0) [20.8–29.1] 724 (23.9) [21.6–26.3]
Main health problem
– Rating (severe)b 135 (26.1) [19.5-32.7] 565 (21.1) [18.9-23.2]
aRating: excellent, very good, good, less well, bad.
bRating: minor, moderate, severe.
Table 5. Physicians’ diagnostic procedure and participating patients’ ra-
ting of health status – survey B
CAM sample COM sample
n (%) [CI] n (%) [CI]
Patients, totala 579 (100) [–] 3094 (100) [–]
Diagnostic procedureb
– Aanamnesis 76 (82.2) [73.4–91.0] 2688 (86.9) [83.3–90.5]
– Examination 387 (66.8) [57.5–76.2] 2430 (78.5) [75.3–81.8]
– X-ray / sono 40 (6.9) [2.8–11.0] 188 (6.1) [4.8–7.3]
– Lab test / ECG 131 (22.6) [17.2–28.0] 741 (23.9) [21.5–26.4]
Main health problem
– Rating (severe) 113 (21.2) [8.4–34.0] 280 (10.1) [8.5–11.7]
aThe numbers of patients differ from those in table 3 and 4 because of dif-
ferent numbers of participants, change of age (e.g. children became adults)
or because physicians did not fill in a form for each participating patient in
this part of survey 2.
bMultiple answers possible.
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Physicians’ rating of the frequency of the main diagnosis did
not differ between the 2 groups, except for diseases of the cir-
culatory system (table 6). In both groups, 60% of all main di-
agnoses fall into the same 6 ICD-10 categories. The number of
co-morbidities was not significantly different between COM
and CAM patients but amounted to more than 50% in both
groups (table 6). 
Investigation of the therapeutic procedures indicates that in
both groups mostly COM methods were used, but CAM
physicians used phytotherapy as an additional treatment sig-
nificantly more often than COM physicians. Phytotherapy
alone was used by CAM physicians in 7.1% of the cases, in
combination with COM therapies in 10.9%, and in combina-
tion with other CAM methods only in 1.7% (table 7).
A significant difference can be seen with regard to drug and
non-drug therapy, with the latter being used significantly more
often by CAM physicians (table 7). A closer look at the subset
of non-drug therapies revealed that counseling is at the top of
the list of non-drug therapies in both groups of physicians. Yet,
the consultation time was found to be 5 min longer in the
CAM physician group. 
Survey B – (2) Patient Questionnaire: The return rate of the
questionnaires mailed 1 month after the second survey was
45% (n = 276) in CAM patients and 54% (n = 1,395) in COM
patients (fig. 1). Yet not all patient questionnaires could be an-
alyzed or provided answers to all questions. This accounts for
the lower number of patients. As to outcome, the SF-36 re-
vealed no differences, neither regarding the patients’ physical
nor their mental health status (table 8). The EUROPEP, on
the other hand, showed significant differences in favor of
CAM physicians, with regard to the sum scores of the category
‘relation and communication’ in terms of the CI and addition-
ally for ‘medical care’ as well as ‘information and support’ in
the multivariate or logistic analysis (table 8). The additional
questions about treatment expectation, satisfaction and side
effects showed similar results in both patient groups.
Discussion
In the papers published so far about the Swiss PEK, results re-
garding four CAM methods (except phytotherapy), seen as
one group (CAM), were compared to COM data [13–15]. This
comparison revealed some differences between CAM and
COM in general. It was the aim of the present paper to per-
form a subgroup analysis of the data of physicians certified in
phytotherapy. Of course, such a task is faced with limitations.
Above all, the sample size is much smaller, which might be a
critical restriction regarding some questions. However, this
might only affect the number of CAM physicians. To cope
with this, we decided to do a descriptive analysis, so as not to
overcharge the results, which we ourselves interpret as a kind
of preliminary data providing an overview of at least some as-
pects of phytotherapy in primary care in Switzerland. The
forte of the present study is that it interviewed both physicians
(all trained in phytotherapy according to the same curriculum)
and their very patients by linking two surveys. 
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Table 7. Therapeutic procedure that physicians chose for the participa-
ting patients – survey B
CAM sample COM sample
n (%) [CI] n (%) [CI]
COM or CAM
– COM  261 (45.1) [–] 2693 (87.0) [–]
– COM + PT 63 (10.9) [–] 14 (0.5) [–]
– PT 41 (7.1) [–] 8 (0.3) [–]
– PT + CAM 10 (1.7) [–] –
Drug or non-drug
– Drug 225 (38.9) [27.4–50.4] 1668 (53.9) [50.5–57.3]
– Non-drug 184 (31.8) [21.7–41.8] 536 (17.3) [15.2–19.4]
– Both 117 (20.2) [12.5–27.9] 566 (18.3) [15.1–21.5]
– None 53 (9.2) [5.9–12.4] 324 (10.5) [8.4–12.5]
Work incapacity 51 (11.7) [6.7–16.7] 319 (14.2) [12.1–16.2]
Consultation, min, mean* 23 ( median 20) 16.9 ( median 15)
* p < 0.05 CAM versus COM (multivariate linear or logistic model).
CAM sample COM sample
n (%) [CI] n (%) [CI]
ICD-10
– M. Musculoskeletal system 108 (18.7) [14.8–22.5] 496 (16.0) [14.3–17.8]
– I. Circulatory system* 49 (8.5) [5.3–11.6] 488 (15.8) [14.1–17.4]
– J. Respiratory system 53 (9.2) [6.9–11.4] 331 (10.7) [9.4–12.0]
– F. Mental/behavioural disorder 61 (10.5) [5.7–15.4] 266 (8.6) [6.8–10.4]
– K. Digestive system 35 (6.0) [3.5–8.6] 189 (6.1) [5.1–7.1]
– E. Endocrine / nutritional 43 (7.4) [5.4–9.5] 171 (5.5) [4.4–6.6]
Number of co-morbidities
– 0 280 (48.4) [35.8–60.9] 1288 (41.6) [37.4–45.9]
– 1 195 (33.7) [26.6–40.8] 954 (30.8) [28.7–32.9]
– >1 104 (17.9) [11.1–24.9] 852 (27.5) [23.9–31.1]
Table 6. Physicians’ classification of the main
diagnosis (after coding according to ICD-10)
and number of co-morbidities of participating
patients – survey B
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The previously published cumulative data of the four groups
of CAM physicians (i.e. anthroposophic medicine, Chinese
herbal medicine, homeopathy, neural therapy) of the observa-
tional study within PEK [13–15] allows a comparison with the
present data of the subgroup analysis of CAM physicians cer-
tified in phytotherapy. The finding, that CAM practices had
less technical equipment (e.g. x-ray, ultrasound) [15] could
only be confirmed for X-ray facilities in practices of phy-
totherapists. The main reasons for consultation according to
ICD-10 were the same in the previous and the present publi-
cation except that circulatory diseases were treated less often
by phytotherapists. The most striking difference between
CAM and COM physicians in the present study is the consul-
tation time spent with their patients, the difference amounting
to 25% (5 min) for physicians certified in phytotherapy. This
result matches with another finding of our study, namely that –
according to the EUROPEP – patients favored communica-
tive and patient-oriented skills of CAM physicians (phytother-
apy), which turned out to have an impact on treatment satis-
faction. This may partly explain that CAM physicians pre-
scribed or delivered more non-drug therapies and was found
in the previous analysis as well [14]. The present subgroup
analysis supports our previous postulate, that patient-orienta-
tion and certain communication skills are important elements
Forsch Komplementärmed 2008;15:82–88Quality Aspects of Phytotherapy in Swiss 
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CAM sample COM sample
Patients, total 289 1450
SF-36, participants, n 170 903
– Physical score, points, mean 48.8 47.9 
– Mental score, points, mean 50.1 47.8 
EUROPEPa, participants, n 276 1395
⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯
n (mean %) [CI] n (mean %) [CI]
⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯
Relation and communication (answers: ‘excellent’), sum* (72.1) [67.8–76.4] (64.1) [62.0–66.3]
– Making you feel you had time during consultation? 193 (71.0) [65.6–76.3] 830 (61.5) [57.7–65.3]
– Interest in your personal situation? 189 (70.3) [65.3–75.2] 802 (60.0) [56.8–63.2]
– Making it easy for you to tell him or her about your problem? 182 (70.3) [65.8–74.7] 598 (62.7) [58.7–66.8]
– Involving you in decisions about your medical care? 163 (66.8) [61.9–71.7] 707 (58.3) [54.6–62.1]
– Listening to you? 204 (77.0) [70.8–83.2] 910 (67.2) [64.2–70.2]
– Keeping your records and data confidential? 183 (77.5) [73.4–81.7] 909 (75.2) [72.4–78.1]
Medical care (answers: ‘excellent’), sum* (45.6) [43.5–47.8] (50.8) [46.4–55.2]
– Quick relief of your symptoms? 64 (28.1) [22.5–33.7] 319 (27.6 ) [25.0–30.3]
– Helping you to perform your normal daily activities? 116 (50.2) [42.9–57.5] 475 (41.3) [38.4–44.1]
– Thoroughness? 178 (68.7) [63.4–74.0] 729 (56.6) [53.1–60.1]
– Physical examination of you? 125 (57.3) [49.4–65.2] 630 (52.7) [49.8–55.6]
– Offering services for preventing diseases (e.g. screening) 77 (46.4) [39.7–53.1] 460 (49.1) [45.5–52.6]
Information and support (answers: ‘excellent’), sum* (62.3) [57.2–67.3] (55.6) [53.3–57.9]
– Explaining the purpose of tests and treatments? 151 (62.9) [58.0–67.8] 737 (59.9) [56.7–63.1]
– Telling what you wanted to know about your symptoms / illness? 184 (70.5) [64.4–76.6] 774 (60.1) [57.0–63.2]
– Helping to deal with emotional problems related to health status? 119 (57.5) [51.7–63.3] 538 (49.6) [46.5–52.8]
– Helping to understand to follow his or her advice? 114 (55.9) [49.6–62.2] 576 (51.4) [48.4–54.4]
Continuity and cooperation (answers: ‘excellent’), sum (59.0) [52.8–65.1] (54.4) [51.7–57.0]
– Knowing what she/he had done or told you during earlier contacts? 123 (58.9) [51.4–66.3] 612 (53.4) [50.0–56.8]
– Preparing you for what to expect from specialists or hospital care? 77 (59.2) [51.6–66.8] 437 (55.7) [51.7–59.7]
Facilities availability and accessibility (answers: ‘excellent’), sum (52.8) [49.5–56.0] (50.4) [48.9–51.9]
– The helpfulness of the staff? 168 (66.9) [59.2–74.7] 892 (66.5) [62.7–70.2]
– Getting an appointment to suit you? 7 (2.6) [0.5–4.8] 16 (1.2) [06–1.8]
– Getting through to the practice on phone? 189 (71.9) [62.3–81.4] 983 (72.4) [69.2–75.6]
– Being able to speak to the GP on the phone? 140 (70.0) [62.7–77.3] 599 (58.3) [54.5–62.0]
– Waiting time in the waiting room? 104 (39.7) [23.0–56.4] 514 (38.2) [32.7–43.6]
– Providing quick services for urgent health problems? 162 (74.7) [67.7–81.7] 834 (71.5) [68.3–74.7]
Additional questions
– Fulfilment of treatment expectation (answers: ‘completely fulfilled) 94 (34.8) [29.6–40.1] 425 (32.5) [29.2–35.7]
– Side effects (answers: ‘yes’) 39 (14.2) [8.8–19.6] 197 (15.0) [12.7–17.3]
– Treatment satisfaction (answers: ‘completely satisfied’) 139 (50.9) [42.0–59.9] 571 (43.3) [40.5–46.2]
aEUROPEP contains 23 questions in 5 categories; answers are given on a 5-point scale ranging from ‘poor’ to ‘excellent’.
Answers listed here are those for ‘excellent’ only.
*p < 0.05 CAM versus COM (multivariate linear or logistic model).
Table 8. Patients’
rating of outcome:
SF-36, EUROPEP,
additional questions
– survey B 
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in therapeutic settings for CAM [26]. Of course, herbal drugs
can surely be described in pharmacological terms. Additional-
ly, they are culturally embedded and individually and subjec-
tively coded for many patients and physicians. Therefore, they
seem to offer much more associative and narrative connota-
tions than other modern drugs. This might be a reason why
they can play a specific role in story telling between patient
and physician [27]. Pharmacosemiotic [28, 29], and in the case
of herbal drugs phytopharmacosemiotic, aspects can be thera-
peutically important and may contribute to treatment benefits.
This, however, would have to be studied in a future trial.
Other surveys about the pattern of use of herbal medicine in
primary care are hardly comparable with the present study
due to different study designs and health care systems: a
Brazilian survey that examined more or less the effect of a
herbal therapy program meant to bridge lacking basic medical
supply [17]; a cross-sectional survey that searched for possible
different ethnic patterns of use of herbal drugs in a multieth-
nic population of a large US-American metropolitan area
[18]; or the surveys in a Swedish health center [16] or among
general practitioners in Scotland [19] which focused on the
concomitant use of herbs.
88 Forsch Komplementärmed 2008;15:82–88 Melzer/Saller/Meier
Conclusions
The preliminary data resulting from the subgroup analysis on
phytotherapy from the observational study within PEK shows
only few differences between CAM and COM physicians in
terms of demographics and practice structure. Yet, patients of
CAM physicians showed better treatment satisfaction than
those of COM physicians, probably due to communicative and
patient-oriented skills and attitudes of the CAM physicians.
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